MK
Munish Kumar Jain
About Munish Kumar Jain
Data last updated:
Munish Kumar Jain was a Director at Ashley Pharmatech Private Limited (2010–2022), Director at Glenford Pharmaceuticals Private Limited (2019–2022) and Director at Maxelder Pharma Private Limited (2020–2022), and held 1 more directorship. The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ashley Pharmatech Private Limited U24230DL2010PTC202596 | Director | 13 May 2010 | 2010 | ₹15.88 Cr (FY 2024) | Active |
 Glenford Pharmaceuticals Private Limited U51909DL2019PTC357636 | Director | 18 Nov 2019 | 2019 | ₹6.91 Cr (FY 2025) | Active |
| Maxelder Pharma Private Limited U51909UP2020PTC134028 | Director | 05 Sep 2020 | 2020 | ₹6.41 Cr (FY 2025) | Active |
| Greenkind Bioscience Private Limited U51909UP2020PTC133925 | Director | 04 Sep 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Munish Kumar Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Munish Kumar Jain
Munish Kumar Jain was first appointed on 13 May 2010 as Director at Ashley Pharmatech Private Limited. The most recent appointment on record is 05 Sep 2020 at Maxelder Pharma Private Limited.
Munish Kumar Jain held 4 earlier board appointments: Ashley Pharmatech Private Limited (Director, 13 May 2010 to 06 Mar 2022); Glenford Pharmaceuticals Private Limited (Director, 18 Nov 2019 to 10 Oct 2022); Maxelder Pharma Private Limited (Director, 05 Sep 2020 to 07 Nov 2022); Greenkind Bioscience Private Limited (Director, from 04 Sep 2020).